Asbjørg Stray-Pedersen1, Hanne Sørmo Sorte2, Pubudu Samarakoon2, Tomasz Gambin3, Ivan K Chinn4, Zeynep H Coban Akdemir5, Hans Christian Erichsen6, Lisa R Forbes4, Shen Gu5, Bo Yuan7, Shalini N Jhangiani8, Donna M Muzny8, Olaug Kristin Rødningen9, Ying Sheng9, Sarah K Nicholas4, Lenora M Noroski10, Filiz O Seeborg10, Carla M Davis10, Debra L Canter10, Emily M Mace11, Timothy J Vece12, Carl E Allen13, Harshal A Abhyankar13, Philip M Boone7, Christine R Beck7, Wojciech Wiszniewski7, Børre Fevang14, Pål Aukrust14, Geir E Tjønnfjord15, Tobias Gedde-Dahl16, Henrik Hjorth-Hansen17, Ingunn Dybedal16, Ingvild Nordøy14, Silje F Jørgensen18, Tore G Abrahamsen19, Torstein Øverland6, Anne Grete Bechensteen6, Vegard Skogen20, Liv T N Osnes21, Mari Ann Kulseth9, Trine E Prescott9, Cecilie F Rustad9, Ketil R Heimdal9, John W Belmont22, Nicholas L Rider4, Javier Chinen10, Tram N Cao4, Eric A Smith23, Maria Soledad Caldirola24, Liliana Bezrodnik24, Saul Oswaldo Lugo Reyes25, Francisco J Espinosa Rosales25, Nina Denisse Guerrero-Cursaru26, Luis Alberto Pedroza26, Cecilia M Poli27, Jose L Franco28, Claudia M Trujillo Vargas28, Juan Carlos Aldave Becerra29, Nicola Wright30, Thomas B Issekutz31, Andrew C Issekutz31, Jordan Abbott32, Jason W Caldwell33, Diana K Bayer34, Alice Y Chan35, Alessandro Aiuti36, Caterina Cancrini37, Eva Holmberg38, Christina West39, Magnus Burstedt38, Ender Karaca5, Gözde Yesil40, Hasibe Artac41, Yavuz Bayram5, Mehmed Musa Atik5, Mohammad K Eldomery5, Mohammad S Ehlayel42, Stephen Jolles43, Berit Flatø44, Alison A Bertuch45, I Celine Hanson4, Victor W Zhang22, Lee-Jun Wong22, Jianhong Hu46, Magdalena Walkiewicz22, Yaping Yang22, Christine M Eng22, Eric Boerwinkle47, Richard A Gibbs8, William T Shearer10, Robert Lyle9, Jordan S Orange48, James R Lupski49. 1. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Center for Human Immunobiology of Texas Children's Hospital/Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Norwegian National Unit for Newborn Screening, Oslo University Hospital, Oslo, Norway; Department of Pediatrics, Oslo University Hospital, Oslo, Norway. Electronic address: astraype@ous-hf.no. 2. Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 3. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Institute of Computer Science, Warsaw University of Technology, Warsaw, Poland. 4. Center for Human Immunobiology of Texas Children's Hospital/Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex. 5. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex. 6. Department of Pediatrics, Oslo University Hospital, Oslo, Norway. 7. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex. 8. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex. 9. Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. 10. Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex. 11. Center for Human Immunobiology of Texas Children's Hospital/Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex. 12. Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex. 13. Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Tex; Texas Children's Cancer and Hematology Center, Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Hospital and Baylor College of Medicine, Houston, Tex. 14. Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. 15. Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Hematology, Oslo University Hospital, Oslo, Norway. 16. Department of Hematology, Oslo University Hospital, Oslo, Norway. 17. Department of Hematology, St Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. 18. Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. 19. Department of Pediatrics, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 20. Department of Infectious Diseases, Medical Clinic, University Hospital of North-Norway, Tromsø, Norway. 21. Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway. 22. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex. 23. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Tex. 24. Immunology Service, Ricardo Gutierrez Children's Hospital, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina. 25. Immunodeficiencies Research Unit, National Institute of Pediatrics, Coyoacan, Mexico City, Mexico. 26. Universidad San Francisco de Quito, Quito, Ecuador. 27. Center for Human Immunobiology of Texas Children's Hospital/Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Hospital Roberto del Rio, Universidad de Chile, Santiago, Chile. 28. Grupo de Inmunodeficiencias Primarias, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellin, Colombia. 29. Allergy and Clinical Immunology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru. 30. Alberta Children's Hospital, Calgary, Alberta, Canada. 31. Department of Pediatrics, Dalhousie University, Izaak Walton Killam Health Centre, Halifax, Nova Scotia, Canada. 32. Department of Pediatrics, National Jewish Health, Denver, Colo. 33. Section of Pulmonary, Critical Care, Allergic and Immunological Diseases, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC. 34. Department of Pediatrics, Division of Pediatric Allergy/Immunology and Pulmonology, University of Iowa Carver College of Medicine, Iowa City, Iowa. 35. Department of Pediatrics, University of California, San Francisco, Calif. 36. San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), and Vita-Salute San Raffaele University, Milan, Italy. 37. University Department of Pediatrics, DPUO, Bambino Gesù Children's Hospital, and Tor Vergata University, Rome, Italy. 38. Department of Clinical Genetics, University Hospital of Umeå, Umeå, Sweden. 39. Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. 40. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Department of Medical Genetics, Bezmi Alem Vakif University Faculty of Medicine, Istanbul, Turkey. 41. Department of Pediatric Immunology and Allergy, Selcuk University Medical Faculty, Alaeddin Keykubat Kampusu, Konya, Turkey. 42. Department of Pediatrics, Section of Pediatric Allergy and Immunology, Hamad Medical Corporation, Doha, Department of Paediatrics, Weill Cornell Medical College, Ar-Rayyan, Qatar. 43. Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, Wales. 44. Department of Rheumatology, Oslo University Hospital, Oslo, Norway. 45. Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Tex. 46. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex. 47. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex; Human Genetics Center, University of Texas School of Public Health, Houston, Tex. 48. Center for Human Immunobiology of Texas Children's Hospital/Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex. Electronic address: orange@bcm.edu. 49. Baylor-Hopkins Center for Mendelian Genomics of the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, Houston, Tex; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Tex; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Tex. Electronic address: jlupski@bcm.tmc.edu.
Abstract
BACKGROUND: Primary immunodeficiency diseases (PIDDs) are clinically and genetically heterogeneous disorders thus far associated with mutations in more than 300 genes. The clinical phenotypes derived from distinct genotypes can overlap. Genetic etiology can be a prognostic indicator of disease severity and can influence treatment decisions. OBJECTIVE: We sought to investigate the ability of whole-exome screening methods to detect disease-causing variants in patients with PIDDs. METHODS: Patients with PIDDs from 278 families from 22 countries were investigated by using whole-exome sequencing. Computational copy number variant (CNV) prediction pipelines and an exome-tiling chromosomal microarray were also applied to identify intragenic CNVs. Analytic approaches initially focused on 475 known or candidate PIDD genes but were nonexclusive and further tailored based on clinical data, family history, and immunophenotyping. RESULTS: A likely molecular diagnosis was achieved in 110 (40%) unrelated probands. Clinical diagnosis was revised in about half (60/110) and management was directly altered in nearly a quarter (26/110) of families based on molecular findings. Twelve PIDD-causing CNVs were detected, including 7 smaller than 30 Kb that would not have been detected with conventional diagnostic CNV arrays. CONCLUSION: This high-throughput genomic approach enabled detection of disease-related variants in unexpected genes; permitted detection of low-grade constitutional, somatic, and revertant mosaicism; and provided evidence of a mutational burden in mixed PIDD immunophenotypes.
BACKGROUND:Primary immunodeficiency diseases (PIDDs) are clinically and genetically heterogeneous disorders thus far associated with mutations in more than 300 genes. The clinical phenotypes derived from distinct genotypes can overlap. Genetic etiology can be a prognostic indicator of disease severity and can influence treatment decisions. OBJECTIVE: We sought to investigate the ability of whole-exome screening methods to detect disease-causing variants in patients with PIDDs. METHODS:Patients with PIDDs from 278 families from 22 countries were investigated by using whole-exome sequencing. Computational copy number variant (CNV) prediction pipelines and an exome-tiling chromosomal microarray were also applied to identify intragenic CNVs. Analytic approaches initially focused on 475 known or candidate PIDD genes but were nonexclusive and further tailored based on clinical data, family history, and immunophenotyping. RESULTS: A likely molecular diagnosis was achieved in 110 (40%) unrelated probands. Clinical diagnosis was revised in about half (60/110) and management was directly altered in nearly a quarter (26/110) of families based on molecular findings. Twelve PIDD-causing CNVs were detected, including 7 smaller than 30 Kb that would not have been detected with conventional diagnostic CNV arrays. CONCLUSION: This high-throughput genomic approach enabled detection of disease-related variants in unexpected genes; permitted detection of low-grade constitutional, somatic, and revertant mosaicism; and provided evidence of a mutational burden in mixed PIDD immunophenotypes.
Authors: Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman Journal: Nature Date: 2014-06-04 Impact factor: 49.962
Authors: Yu Zhang; Xiaomin Yu; Mie Ichikawa; Jonathan J Lyons; Shrimati Datta; Ian T Lamborn; Huie Jing; Emily S Kim; Matthew Biancalana; Lynne A Wolfe; Thomas DiMaggio; Helen F Matthews; Sarah M Kranick; Kelly D Stone; Steven M Holland; Daniel S Reich; Jason D Hughes; Huseyin Mehmet; Joshua McElwee; Alexandra F Freeman; Hudson H Freeze; Helen C Su; Joshua D Milner Journal: J Allergy Clin Immunol Date: 2014-02-28 Impact factor: 10.793
Authors: Ender Karaca; Tamar Harel; Davut Pehlivan; Shalini N Jhangiani; Tomasz Gambin; Zeynep Coban Akdemir; Claudia Gonzaga-Jauregui; Serkan Erdin; Yavuz Bayram; Ian M Campbell; Jill V Hunter; Mehmed M Atik; Hilde Van Esch; Bo Yuan; Wojciech Wiszniewski; Sedat Isikay; Gozde Yesil; Ozge O Yuregir; Sevcan Tug Bozdogan; Huseyin Aslan; Hatip Aydin; Tulay Tos; Ayse Aksoy; Darryl C De Vivo; Preti Jain; B Bilge Geckinli; Ozlem Sezer; Davut Gul; Burak Durmaz; Ozgur Cogulu; Ferda Ozkinay; Vehap Topcu; Sukru Candan; Alper Han Cebi; Mevlit Ikbal; Elif Yilmaz Gulec; Alper Gezdirici; Erkan Koparir; Fatma Ekici; Salih Coskun; Salih Cicek; Kadri Karaer; Asuman Koparir; Mehmet Bugrahan Duz; Emre Kirat; Elif Fenercioglu; Hakan Ulucan; Mehmet Seven; Tulay Guran; Nursel Elcioglu; Mahmut Selman Yildirim; Dilek Aktas; Mehmet Alikaşifoğlu; Mehmet Ture; Tahsin Yakut; John D Overton; Adnan Yuksel; Mustafa Ozen; Donna M Muzny; David R Adams; Eric Boerwinkle; Wendy K Chung; Richard A Gibbs; James R Lupski Journal: Neuron Date: 2015-11-04 Impact factor: 17.173
Authors: Andrea M Siegel; Kelly D Stone; Glenn Cruse; Monica G Lawrence; Ana Olivera; Mi-yeon Jung; John S Barber; Alexandra F Freeman; Steven M Holland; Michelle O'Brien; Nina Jones; Celeste G Nelson; Laura B Wisch; Heidi H Kong; Avanti Desai; Orly Farber; Alasdair M Gilfillan; Juan Rivera; Joshua D Milner Journal: J Allergy Clin Immunol Date: 2013-11-01 Impact factor: 10.793
Authors: Stella P Hartono; Alexander Vargas-Hernández; Mark J Ponsford; Ivan K Chinn; Stephen Jolles; Keith Wilson; Lisa R Forbes Journal: J Clin Immunol Date: 2018-10-13 Impact factor: 8.317
Authors: Francisco Requena; Hamza Hadj Abdallah; Alejandro García; Patrick Nitschké; Sergi Romana; Valérie Malan; Antonio Rausell Journal: Nucleic Acids Res Date: 2021-07-02 Impact factor: 16.971
Authors: Raquel Ruiz-García; Alexander Vargas-Hernández; Ivan K Chinn; Laura S Angelo; Tram N Cao; Zeynep Coban-Akdemir; Shalini N Jhangiani; Qingchang Meng; Lisa R Forbes; Donna M Muzny; Luis M Allende; Mohammed S Ehlayel; Richard A Gibbs; James R Lupski; Gulbu Uzel; Jordan S Orange; Emily M Mace Journal: J Allergy Clin Immunol Date: 2018-01-10 Impact factor: 10.793
Authors: Jennifer R Heimall; David Hagin; Joud Hajjar; Sarah E Henrickson; Hillary S Hernandez-Trujillo; Yuval Tan; Lisa Kobrynski; Kenneth Paris; Troy R Torgerson; James W Verbsky; Richard L Wasserman; Elena W Y Hsieh; Jack J Blessing; Janet S Chou; Monica G Lawrence; Rebecca A Marsh; Sergio D Rosenzweig; Jordan S Orange; Roshini S Abraham Journal: J Clin Immunol Date: 2018-04-19 Impact factor: 8.317
Authors: Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes Journal: J Allergy Clin Immunol Date: 2017-10-27 Impact factor: 10.793